MENU
+Compare
SSKN
Stock ticker: NASDAQ
AS OF
Jan 23, 02:03 PM (EDT)
Price
$2.91
Change
+$0.02 (+0.69%)
Capitalization
13.25M

SSKN Strata Skin Sciences Forecast, Technical & Fundamental Analysis

a manufacturer of dermatology treatment products

SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SSKN with price predictions
Jan 08, 2025

SSKN's Indicator enters downward trend

The Aroon Indicator for SSKN entered a downward trend on December 27, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 207 similar instances where the Aroon Indicator formed such a pattern. In of the 207 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSKN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 74 cases where SSKN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on SSKN as a result. In of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SSKN just turned positive on January 03, 2025. Looking at past instances where SSKN's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

SSKN moved above its 50-day moving average on January 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.105) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.419) is also within normal values, averaging (41.167).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SSKN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SSKN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
SSKN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a manufacturer of dermatology treatment products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
5 Walnut Grove Drive
Phone
+1 215 619-3200
Employees
114
Web
https://www.strataskinsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMCI9.430.16
+1.73%
Treace Medical Concepts
HBIO1.95N/A
N/A
Harvard Bioscience
YUMC44.90-0.09
-0.20%
Yum China Holdings
SVV11.26-0.17
-1.49%
Savers Value Village
PETZ1.21-0.04
-3.21%
TDH Holdings

SSKN and Stocks

Correlation & Price change

A.I.dvisor tells us that SSKN and VERO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSKN and VERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSKN
1D Price
Change %
SSKN100%
+0.35%
VERO - SSKN
30%
Poorly correlated
+3.85%
DCTH - SSKN
26%
Poorly correlated
+1.54%
NAYA - SSKN
25%
Poorly correlated
-2.81%
ANIK - SSKN
25%
Poorly correlated
-1.70%
ARAY - SSKN
22%
Poorly correlated
+1.79%
More